Erectile Dysfunction Meds Tied to Higher Risk for Vision Issues

MONDAY, April 11, 2022 -- Regular users of phosphodiesterase type 5 inhibitors (PDE5Is) for erectile dysfunction may have an increased risk for adverse ocular events, according to a study published online April 7 in JAMA Ophthalmology. Mahyar...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news